About

Company description

CPC Scientific is a globally recognized and leading CDMO specializing in synthetic peptide production. We work directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. We boast the largest peptide facility in the world, which successfully has undergone multiple FDA inspections and audits by global pharma organizations. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing.

Quick facts

Sales markets Western Europe; Eastern Europe; Australia; North America; Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Biotechnology and related specialities More

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 944 See our Exhibitor Profile   See full Exhibitor List

News about CPC Scientific

CPC Scientific Inc. and UNC Lineberger Comprehensive Cancer Center Announce Neoantigen Peptide Collaboration to Manufacture Neoantigen Peptides for the PANDA (Personalized and Adaptive) Cancer Vaccine Program.

7 Mar 2019

CPC Scientific Inc. and UNC Lineberger Comprehensive Cancer Center Announce Neoantigen Peptide Collaboration to Manufacture Neoantigen Peptides for the PANDA (Personalized and Adaptive) Cancer Vaccine Program.

CPC Scientific Inc., a leading global CDMO specializing in synthetic peptide manufacturing, announced today that they will manufacture GMP-grade neoantigen peptides for investigators at UNC Lineberger Comprehesive Cancer Center (LCCC) for the purpose of individualized immunotherapy.

Read more
CPC Scientific

Contact information

Address

Telephone

Website

View all contact information